India's Venus Remedies jump on Spain approving anti-bacterial drug

Venus Remedies

22/06/2023 07:17

** Shares of Venus Remedies  VENR.NS  rise as much as 4.87%
at 251.00 rupees 
    ** Co says it received approval to market its anti-bacterial
drug meropenem in Spain
    ** Co says annual sales of meropenem in 2022-23 stood at $27
mln; estimated to grow to $29.7 mln in 2023-24
    ** Shares on track to snap two sessions of losses, and
trading above 50-, 100- and 200-day exponential moving avgs
    ** Including session's gains, stock up ~37% YTD

 (Reporting by Hritam Mukherjee in Bengaluru)
 ((Hritam.Mukherjee@thomsonreuters.com;))